Andrew Kelly

Andrew Philip Kelly is the founder of BioPacific Ventures Ltd. (founded in 2005) and Biopacific Partners, Inc. (founded in 2014).
At Biopacific Partners, Inc., he holds the title of Executive Director.
Dr. Kelly's former jobs include Non-Executive Chairman at The Calmer Co International Ltd. (2018-2023), Director at Wool Equities Ltd., Independent Non-Executive Director at Algorae Pharmaceuticals Ltd. (2019-2022), Director at AgResearch Ltd., Executive Director at Direct Capital Private Equity Ltd., Director at Cleveland Biosensors Pty Ltd., Director at Anzamune Ltd., Director at EnCoate Holdings Ltd., Director at Horizon Science Pty Ltd., Director at Rissington Breedline Ltd., Director at CMP Therapeutics Ltd., Director at Focus Genetics SA Ltd., Director at Ultrafine Merino Co. Ltd., Director at Velvet Antler Research New Zealand Ltd., and Director at Inner Vision Ltd. Dr. Kelly's education includes an undergraduate and doctorate degree from the University of Melbourne and a graduate degree from the University of Saskatchewan.